Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells have?
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells has 58 citations in the OpenAlex counts ScholarIQ stores.
When was Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells published?
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells has 2016 year in the ScholarIQ index.
What is the open-access status of Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells?
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells has gold oa status in the ScholarIQ index.
What is the DOI of Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells?
The DOI for Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells is on the source record.
What is the PMID of Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells?
The PMID for Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells is on the source record.
What is the OpenAlex record for Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells?
The OpenAlex for Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells is on the source record.